Tp53 - Globe Thesis - Globe Thesis

Keyword [Tp53] Result: 121 - 140 \| Page: 7 of 8
121.	Exploration Of Circulating Tumor DNA As A Therapeutic Response And Prognostic Biomarker In Advanced Breast Cancer
122.	Pediatric Rhabdomyosarcoma With TP53 Gene Mutation
123.	Functions Of Mcm5 And Its Mechanism In The Carcinogenesis Of Endometrial Serous Carcinoma
124.	Effect And Mechanism Of Sirtuin 7 Deacetylase On Occurrence And Progression In Prostate Cancer
125.	Clinical Application Of MMR And P53 Detection In Endometrial Cancer And The Research Of Differentially Expressed Genes
126.	Mutation Of High-frequency Mutated Genes And Tumor Susceptibility Genes In High-grade Serous Ovarian Cancer By Whole-exome Sequencing
127.	Clinical Characteristics And Prognostic Value Analysis Of DLBCL Patients With TP53 Gene Variation Detected By Next Generation Sequencing And FISH
128.	Predictive And Prognostic Potential Of TP53 In Patients With EGFR-mutant Advanced Non-small Cell Lung Cancer
129.	Clinical And Prognostic Implications Of An Immune-related Model(IRM) Based On TP53 Status In Lung Adenocarcinoma
130.	Prognostic Value Of TP53 Mutation In Patients With Advanced Non-small Cell Lung Cancer With EGFR Mutation
131.	Study On The Feature Of Lymphoma-associated Driver Gene Aberration For Double-expression Diffuse Large B Cell Lymphoma
132.	A Case Report And Literature Review Of Follicular Lymphoma With TP53 Mutated Transformed Into Diffuse Large B Cell Lymphoma
133.	The Effect Of TP53 Mutation Type On The Prognosis Of NSCLC Patients With Different Pathological Subtypes
134.	Association Between TP53,HER2 Gene Mutation And The Over-expression Of Protein And Clinicopathological Features In Gastric Cancer
135.	Antitumor Effect Of Modified TP53 Shared Neoantigen On Liver Cancer
136.	Correlation Between Abnormal Expression Of KRAS,PIK3CA,APC,TP53 Genes And Clinical Characteristics Of Colorectal Cancer Patients
137.	Mass Cytometry Analysis Construct The Immune Atlas Of Hepatocellular Carcinoma With HBV
138.	Potential Predictive Value Of TP53 And ARID1A Co-mutation To Immune Checkpoint Inhibitors Therapy In Gastric Cancer
139.	Pilot Application Of New Molecular Diagnotic Technology In Hepatobiliary Tumors
140.	Clinical Implications Of TP53 Mutations In Metastatic Breast Cancer
<<First <Prev Next> Last>> Jump to